{"title":"化疗引起的周围神经病变","authors":"S. Prinsloo","doi":"10.5298/1081-5937-50.1.03","DOIUrl":null,"url":null,"abstract":"Chemotherapy-induced peripheral neuropathy (CIPN) can be considered a phantom pain because the sensations of CIPN have no concurrent input into the nervous system. In fact, the damage that is done to the peripheral nerves is, as we know to date, irreversible. There are limited data supporting the use of neuromodulatory techniques to treat CIPN and no trials with aims for prevention. The objective of this article is to review current research on neurofeedback to treat CIPN.","PeriodicalId":75596,"journal":{"name":"Biofeedback and self-regulation","volume":"8 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Chemotherapy-Induced Peripheral Neuropathy\",\"authors\":\"S. Prinsloo\",\"doi\":\"10.5298/1081-5937-50.1.03\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Chemotherapy-induced peripheral neuropathy (CIPN) can be considered a phantom pain because the sensations of CIPN have no concurrent input into the nervous system. In fact, the damage that is done to the peripheral nerves is, as we know to date, irreversible. There are limited data supporting the use of neuromodulatory techniques to treat CIPN and no trials with aims for prevention. The objective of this article is to review current research on neurofeedback to treat CIPN.\",\"PeriodicalId\":75596,\"journal\":{\"name\":\"Biofeedback and self-regulation\",\"volume\":\"8 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biofeedback and self-regulation\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5298/1081-5937-50.1.03\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biofeedback and self-regulation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5298/1081-5937-50.1.03","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Chemotherapy-induced peripheral neuropathy (CIPN) can be considered a phantom pain because the sensations of CIPN have no concurrent input into the nervous system. In fact, the damage that is done to the peripheral nerves is, as we know to date, irreversible. There are limited data supporting the use of neuromodulatory techniques to treat CIPN and no trials with aims for prevention. The objective of this article is to review current research on neurofeedback to treat CIPN.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
